http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009544659-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-16 |
| filingDate | 2007-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009544659-A |
| titleOfInvention | Quinuclidine derivatives as M3 antagonists |
| abstract | General formula (I) in the form of one enantiomer or a mixture thereof [Chemical 1] [Where, R 1 is selected from H, F, Cl, Br, I and (C 1 -C 4 ) -alkyl; R 2 is optionally substituted 2 or 3-thienyl, or substituted phenyl; R 3 is (CH 2 ) 1-4 -COR 4 or (CH 2 ) 1-4 -S (O) n R 4 , where R 4 is optionally substituted phenyl or optionally substituted 2 Or 3-thienyl; n is 0, 1 or 2; X − is a pharmaceutically acceptable anion. The quinuclidine derivatives are useful for the manufacture of a medicament for the prevention and treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, cough and emphysema. |
| priorityDate | 2006-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.